Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, November 2000, p. 3069-3073, Vol. 44, No. 11
Department of Bacteriology, School of Medicine,
Niigata University, 757 Ichibanchou, Niigata, Japan
Received 26 April 2000/Returned for modification 7 June
2000/Accepted 3 August 2000
The motility of Helicobacter pylori was maximum at
37°C and at pH 6. A newly developed proton pump inhibitor,
rabeprazole (RPZ), and its thioether derivative (RPZ-TH) markedly
inhibited the motility of H. pylori. The
concentrations of the drug necessary to inhibit 50% of the motility
were 0.25, 16, 16, and >64 µg/ml for RPZ-TH, RPZ, lansoprazole, and
omeprazole, respectively. No such inhibitory effects were observed with
H2 blockers or anti-H. pylori agents. The
motilities of Campylobacter jejuni and C. coli
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
A Novel Action of the Proton Pump Inhibitor Rabeprazole and Its
Thioether Derivative against the Motility of Helicobacter
pylori

but not those of Vibrio cholerae O1 and O139,
Vibrio parahaemolyticus, Salmonella enterica
serovar Typhimurium, and Proteus mirabilis
were also
inhibited. Prolonged incubation with RPZ or RPZ-TH inhibited bacterial
growth of only H. pylori, except for a turbid colony mutant. The results indicate that RPZ and RPZ-TH have a characteristic inhibitory effect against the motility of H. pylori
(spiral-shaped bacteria), which is distinguished from that against
bacterial growth.
*
Corresponding author. Mailing address: Department of
Bacteriology, School of Medicine, Niigata University, 757 Ichibanchou, Asahimachidori, Niigata, Japan. Phone: 81-25-227-2050. Fax:
81-25-227-0762. E-mail:
tatsuoy{at}med.niigata-u.ac.jp.
Present address: Tsukuba University, Tsukuba, Ibaraki, Japan.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»